echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Monitoring of 10,000 adverse reactions in thermal-poisonin injections

    Monitoring of 10,000 adverse reactions in thermal-poisonin injections

    • Last Update: 2020-07-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    reporter from Jiangsu Kangyuan Pharmaceutical Co., Ltdwas informed that the company and Jiangsu Provincedrugadverse reactionsmonitoring center jointly carried out the clinical monitoring of 10,000 cases of ADR of the hot toxicine injection has been successfully completed recentlyThrough 1 year's work, this ADR clinical monitoring has achieved good research results, not only comprehensively examined the efficacy and safety of thermal tannin injection in large-scale population after the market, but also provided important reference data for the clinical rational use ofdrugThe hot poisoninjection is a pure Chinese medicine injection independently developed by Jiangsu Kangyuan Pharmaceutical Co., Ltd., and is mainly used in clinical treatment of upper respiratory tract infection (
    Chinese medicinedialectics for external wind fever certificate) caused by high fever, micro-nasty wind chill, head and body pain, cough, sputum yellow and other diseases, the drug since the market in August 2005, to obtain good clinical resultsIn order to better ensure the efficacy and safety of large-scale population use after the market of the hot-toxin injection, we have long attached great importance to thesafety of thedrug Kangyuan Pharmaceutical Industry, and cooperated with theMonitoring Center for Adverse Reactions of Pharmaceuticalin Jiangsu Province to conduct 10,000 cases of
    hot-poison injection spentcentralized ADR monitoring and research in hospitals According to reporters, this ADR monitoring study uses drug-oriented forward-looking centralized monitoring, the use of multi-center, non-controlled observation al-study, the study of all patients in Jiangsu Province using pyrotoxic infusion The scope of monitoring in Suzhou, Wuxi, Changzhou, Nanjing, Xuzhou, Huai'an and other places of 48 hospitals , a total of 10000 valid by the prescription doctor to fill out the monitoring record form, unified recovery, accurate verification and entry of the database, using descriptive analysis, Logistic regression and other methods of research and analysis At the same time, in the process of collecting the monitoring table, the researchers visited all the hospitals participating in the study as well as the department of drug use, the drug doctors reported that the safety of the pyrotoxin injection is good, did not find serious adverse reactions Individual patients develop edited rashes, but disappear naturally after discontinuation In terms of efficacy has also been widely recognized by doctors, patients take medication after two days of symptoms basically return edited back to normal The study of ADR monitoring of the 10,000 cases of hot toxicine injections conducted by Kangyuan Pharmaceuticalco in cooperation with the Drug Adverse Reaction Monitoring Center of Jiangsu Province not only promoted the clinical application of innovative Chinese medicine injections, but also opened a new model of drug safety ADR monitoring in China, and proved the feasibility of a new method of monitoring adverse drug reactions, namely, ADR monitoring in cooperation between the government and enterprises At the same time, the voluntary reporting system of drug ADR monitoring will also be a useful complement to the voluntary reporting system of drug ADR monitoring in China
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.